Short Description Editas Medicine develops crispr gene editing therapeutics to support healthy longevity.
Description Editas Medicine is a biotechnology innovator targeting the fundamental mechanisms of aging through crispr gene editing therapeutics. The company leverages advancements in gene editing and collaborates with leading institutions to translate cutting‑edge science into practical interventions. By focusing on science‑backed solutions, Editas Medicine aims to extend healthspan and improve quality of life across the globe.
Address 11 Hurley St, Cambridge, MA, USA